Log In
Print
BCIQ
Print
Print this Print this
 

ANG2004

  Manage Alerts
Collapse Summary General Information
Company Angiochem Inc.
DescriptionLeptin-based engineered peptide compound (EPiC)
Molecular Target Low-density lipoprotein-related protein 1 alpha-2-macroglobulin receptor (LRP1) (CD91)
Mechanism of Action 
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today